# Small-Molecule Oral Versus Injectable Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Comparative Efficacy, Safety, and Future Clinical Perspectives - Cureus

*Источник: Cureus*
*Дата: 2026-04-16*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMikwJBVV95cUxQU3h2Yi1iSzhkV2JzZ0I4dVdxZ2lfNExiLXB1YksxTDNsdVhCenNza2hxRE1rQ2tJVjVuWXF2MmZ0OHIwbi02Q2h2bmo2SnZNeFY0Yl9Xekc4czlKZzhXSEhVWlV5b29CeVZ2UktaRnhkamE1ZDk5MHFiV2NkamJMMXoyMDlfb2w5eVZ4SGJNeWNRNjVnUnRIcC1kbS1oMi1xZzlqWVJBQjJJTlpXN1d0YnpVdzk4N1ZOcndnMGVuSW4zVW5WSklmTEJnT3ZZRE9pc2N3dWhLeExtcC1odTg2dUV0ZVI4eTNXckxLUXhsdzZfQ3BzSk5ZMV9TanRRQmkta0ZiYnUzMTVEMG1fMkJYckFIWQ?oc=5" target="_blank">Small-Molecule Oral Versus Injectable Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Comparative Efficacy, Safety, and Future Clinical Perspectives</a>&nbsp;&nbsp;<font color="#6f6f6f">Cureus</font>

[Оригинал](https://www.cureus.com/articles/465088-small-molecule-oral-versus-injectable-glucagon-like-peptide-1-glp-1-receptor-agonists-comparative-efficacy-safety-and-future-clinical-perspectives)